Investigation of Expression and Methylation Status of ELF5 Gene Promoter in Patients with Breast Cancer

Introduction: Breast cancer is the most prevalent cancer among Iranian women. ELF5 gene as a transcription factor member of the ETS family could play a key role in breast cancer neoplasms, especially basal-like and endocrine-resistant subtypes. The changes in the gene promoter methylation pattern ar...

Full description

Bibliographic Details
Main Authors: Azar Heidarizadi, Mahdieh Salimi, Hossein Mozdarani
Format: Article
Language:fas
Published: Ilam University of Medical Sciences 2020-10-01
Series:Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām
Subjects:
Online Access:http://sjimu.medilam.ac.ir/article-1-6003-en.html
_version_ 1818564766411522048
author Azar Heidarizadi
Mahdieh Salimi
Hossein Mozdarani
author_facet Azar Heidarizadi
Mahdieh Salimi
Hossein Mozdarani
author_sort Azar Heidarizadi
collection DOAJ
description Introduction: Breast cancer is the most prevalent cancer among Iranian women. ELF5 gene as a transcription factor member of the ETS family could play a key role in breast cancer neoplasms, especially basal-like and endocrine-resistant subtypes. The changes in the gene promoter methylation pattern are considered proper targets in the therapeutic strategies. This study aimed to investigate the frequency of this epigenetic phenomenon and ELF5 gene expression as well as their association with pathologic and clinical characteristics of Iranian patients suffering from this cancer.   Materials & Methods: In order to investigate the ELF5 promoter methylation, 134 breast tissues were analyzed using methylation-specific PCR method. Moreover, 164 tumoral and 10 normal breast tissues retrieved from breast reduction surgery were assessed using Real-Time RT-PCR to analyze the gene expression. Ethics code: 52d/4922, 6.10.2016   Findings: The data revealed that about 70% of the breast cancer tumoral specimens showed ELF5 promoter methylated pattern. Furthermore, the down-regulation of ELF5 gene expression was significantly associated with higher cancer stages, being triple-negative, and invasion.   Discussions & Conclusions: The results revealed that an increase in the ELF5 promoter methylation frequency in patients, compared to the control tissues, and its association with poor prognosis indicators may propose the ELF5 promoter methylation as a possible candidate in further studies to confirm the poor prognostic role of this biomarker in breast cancer.
first_indexed 2024-12-14T01:32:53Z
format Article
id doaj.art-0be52da4439c41afb8b223ed87dcf9d7
institution Directory Open Access Journal
issn 1563-4728
2588-3135
language fas
last_indexed 2024-12-14T01:32:53Z
publishDate 2020-10-01
publisher Ilam University of Medical Sciences
record_format Article
series Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām
spelling doaj.art-0be52da4439c41afb8b223ed87dcf9d72022-12-21T23:21:58ZfasIlam University of Medical SciencesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām1563-47282588-31352020-10-012846678Investigation of Expression and Methylation Status of ELF5 Gene Promoter in Patients with Breast CancerAzar Heidarizadi0Mahdieh Salimi1Hossein Mozdarani2 Dept of Genetics, Fars Science and Research Branch, Islamic Azad University, Marvdasht, Iran Dept of Medical Genetics, Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran Dept of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran Introduction: Breast cancer is the most prevalent cancer among Iranian women. ELF5 gene as a transcription factor member of the ETS family could play a key role in breast cancer neoplasms, especially basal-like and endocrine-resistant subtypes. The changes in the gene promoter methylation pattern are considered proper targets in the therapeutic strategies. This study aimed to investigate the frequency of this epigenetic phenomenon and ELF5 gene expression as well as their association with pathologic and clinical characteristics of Iranian patients suffering from this cancer.   Materials & Methods: In order to investigate the ELF5 promoter methylation, 134 breast tissues were analyzed using methylation-specific PCR method. Moreover, 164 tumoral and 10 normal breast tissues retrieved from breast reduction surgery were assessed using Real-Time RT-PCR to analyze the gene expression. Ethics code: 52d/4922, 6.10.2016   Findings: The data revealed that about 70% of the breast cancer tumoral specimens showed ELF5 promoter methylated pattern. Furthermore, the down-regulation of ELF5 gene expression was significantly associated with higher cancer stages, being triple-negative, and invasion.   Discussions & Conclusions: The results revealed that an increase in the ELF5 promoter methylation frequency in patients, compared to the control tissues, and its association with poor prognosis indicators may propose the ELF5 promoter methylation as a possible candidate in further studies to confirm the poor prognostic role of this biomarker in breast cancer.http://sjimu.medilam.ac.ir/article-1-6003-en.htmlbreast neoplasmself5epigeneticsgene expressionmethylation
spellingShingle Azar Heidarizadi
Mahdieh Salimi
Hossein Mozdarani
Investigation of Expression and Methylation Status of ELF5 Gene Promoter in Patients with Breast Cancer
Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām
breast neoplasms
elf5
epigenetics
gene expression
methylation
title Investigation of Expression and Methylation Status of ELF5 Gene Promoter in Patients with Breast Cancer
title_full Investigation of Expression and Methylation Status of ELF5 Gene Promoter in Patients with Breast Cancer
title_fullStr Investigation of Expression and Methylation Status of ELF5 Gene Promoter in Patients with Breast Cancer
title_full_unstemmed Investigation of Expression and Methylation Status of ELF5 Gene Promoter in Patients with Breast Cancer
title_short Investigation of Expression and Methylation Status of ELF5 Gene Promoter in Patients with Breast Cancer
title_sort investigation of expression and methylation status of elf5 gene promoter in patients with breast cancer
topic breast neoplasms
elf5
epigenetics
gene expression
methylation
url http://sjimu.medilam.ac.ir/article-1-6003-en.html
work_keys_str_mv AT azarheidarizadi investigationofexpressionandmethylationstatusofelf5genepromoterinpatientswithbreastcancer
AT mahdiehsalimi investigationofexpressionandmethylationstatusofelf5genepromoterinpatientswithbreastcancer
AT hosseinmozdarani investigationofexpressionandmethylationstatusofelf5genepromoterinpatientswithbreastcancer